2003
DOI: 10.1111/j.1708-8208.2003.tb00192.x
|View full text |Cite
|
Sign up to set email alerts
|

Space‐Providing Expanded Polytetrafluoroethylene Devices Define Alveolar Augmentation at Dental Implants Induced by Recombinant Human Bone Morphogenetic Protein 2 in an Absorbable Collagen Sponge Carrier

Abstract: The data from this study suggest that a space-providing macroporous ePTFE device defines rhBMP-2/ACS-induced alveolar augmentation to provide adequate bone quantities for implant dentistry. The dental implant surface technology does not appear to substantially influence bone formation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
75
2
1

Year Published

2004
2004
2016
2016

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(82 citation statements)
references
References 38 publications
4
75
2
1
Order By: Relevance
“…Nevertheless, rhBMP-2/ACS-induced bone formation exhibited considerably variable geometry; at times only a thin layer of bone wallpapered the root of the threads of the bone-anchoring implant surface. Apparently, the ACS carrier was ineffective to consistently support relevant rhBMP-2 induced bone formation also shown in parallel studies using a panel of rhBMP-2 concentrations (Tatakis et al 2002;Wikesjö et al 2003;Lu et al 2013). This apparent variability in bone formation could have several geneses including rhBMP-2 dose and release kinetics or bioavailability, but also reflect ACS structural integrity, biodegradation, degree of soak-load, or any combination(s) thereof.…”
Section: Alveolar Augmentationmentioning
confidence: 81%
See 1 more Smart Citation
“…Nevertheless, rhBMP-2/ACS-induced bone formation exhibited considerably variable geometry; at times only a thin layer of bone wallpapered the root of the threads of the bone-anchoring implant surface. Apparently, the ACS carrier was ineffective to consistently support relevant rhBMP-2 induced bone formation also shown in parallel studies using a panel of rhBMP-2 concentrations (Tatakis et al 2002;Wikesjö et al 2003;Lu et al 2013). This apparent variability in bone formation could have several geneses including rhBMP-2 dose and release kinetics or bioavailability, but also reflect ACS structural integrity, biodegradation, degree of soak-load, or any combination(s) thereof.…”
Section: Alveolar Augmentationmentioning
confidence: 81%
“…Healing interval 8 weeks. From Wikesjö et al (2003Wikesjö et al ( , 2004, figure copyrighted by and modified with permission from Wiley-Blackwell…”
Section: Alveolar Augmentationmentioning
confidence: 99%
“…Une autre étude préclinique indique que ACS/rhBMP-2 devrait être mis en place dans la même séance que l'extraction pour plus d'efficacité [45]. Il semblerait que l'on exploite mieux les capacités de l'éponge de collagène chargée en facteur de croissance en l'associant avec une matrice rigide ou du TCP [46][47][48].…”
Section: Discussionunclassified
“…91 Therefore, a collagen-based carrier need to be modified to provide space for bone formation and maturation during the more advanced stages of healing. 92 The combination of collagen with other natural and synthetic materials has also been explored recently and collagen gels, microparticles, and other modified forms of collagen have also been comprehensively reported as carrier vehicles for growth factor delivery in periodontal regeneration. To date, collagen-based devices, including GTR membranes, 42 sponge/hydrogel growth factor delivery vehicles [26][27][28]30,31 and tissue scaffolds, 87,92 hold considerable promise for the future in periodontal regeneration and clinical dental implantation.…”
Section: Collagenmentioning
confidence: 99%
“…127 * a space-providing macroporous expanded polytetrafluoroethylene device, 92 an ACS carrier, 30 and a bioresorbable PLA barrier device (Atrisorb) 168 * a Dex-GMA/gelatin system developed in our previous work. 34,41,95 Growth factor delivery systems are synthesized based on the appropriate materials using different delivery approaches.…”
Section: Growth Factor Delivery Systems and Devicesmentioning
confidence: 99%